Catalyxx, a Spanish cleantech company, has announced plans to construct a €120 million commercial-scale bio-based chemicals manufacturing facility in Sines, Portugal. The investment marks a significant expansion for the company and reflects growing European momentum toward developing sustainable alternatives to petroleum-derived chemicals.
The Catalyxx Ibérica plant will focus on producing drop-in chemicals including butanol, hexanol and octanol derived from bioethanol. These products are chemically identical to their fossil-fuel counterparts but manufactured through a renewable process, positioning them as direct replacements for conventional industrial applications. The facility is expected to reduce carbon dioxide emissions by approximately 105,000 tonnes annually compared to traditional production methods.
Financing and Public Support
The project has secured funding through a combination of private capital and public financial mechanisms. The €20 million grant from the Circular Bio-based Europe Joint Undertaking represents a key component of the funding structure, alongside contributions from the European Investment Bank and private investors. This mixed financing approach underscores the project’s alignment with European Union priorities around circular economy development and climate mitigation.
“Our Catalyxx Ibérica facility represents the next step in Catalyxx’s mission to replace fossil-based chemicals with renewable alternatives that are chemically identical, fully compatible with existing industrial applications and significantly lower in carbon intensity,” stated Joaquín Alarcón, Chief Executive Officer of Catalyxx. Construction of the facility is scheduled to commence in the fourth quarter of 2026.
Company Background and Growth
Founded in 2017, Catalyxx operates within the bio-based chemicals sector and has raised €78.3 million in total funding to date. The Sines project represents both a scaling of production capacity and part of the company’s strategy to expand its international presence across Europe. By establishing manufacturing infrastructure in Portugal, the company positions itself to serve European industrial customers while benefiting from the country’s existing port facilities and logistics networks.
Broader European Context
The investment reflects a wider transition occurring across the European chemicals industry, where producers increasingly seek sustainable alternatives to traditional feedstocks. The European Union’s Circular Bio-based Europe Joint Undertaking, which provided substantial support for this project, was established to accelerate the development and deployment of bio-based technologies that support climate goals and reduce dependence on fossil resources.
Catalyxx’s expansion to Portugal comes as other European biotech and cleantech firms pursue similar strategies of building manufacturing capacity closer to end markets. The availability of public funding mechanisms combined with private capital demonstrates continued investor confidence in the commercial viability of bio-based chemical production at scale, even as the sector remains relatively nascent in terms of industrial deployment.